Cutaneous Malignancies Have High Response to Oncolytic Virus Plus Immunotherapy
Elisa Becze, BA, ELS, Editor
Voice
Description
Combination treatment with an oncolytic virus plus a PD-1 inhibitor shows promise in patients with nonmelanoma skin cancers, researchers reported in early study results during the 2022 Multidisciplinary Head and Neck Cancers Symposium.